Werewolf Therapeutics, Inc. (HOWL) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US95075A1079
Werewolf Therapeutics, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Operating income | -60.68 m USD |
| EBIT | -58.66 m USD |
| Net income | -60.82 m USD |
| Diluted EPS – continuing operations | -1.33 USD |
Full history since 2019, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Werewolf Therapeutics, Inc.
Werewolf Therapeutics, Inc., a biopharmaceutical company, engages in the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. The company designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies through its proprietary PREDATOR platform. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule for the treatment of advanced or metastatic solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule for the treatment of advanced or metastatic solid tumors and lymphoma. The company is also developing JZP898, a conditionally activated interferon alpha INDUKINE molecule for the treatment of cancer; WTX-921, a conditionally activated IL-10 INDUKINE molecule for the treatment of inflammatory bowel disease and potentially other inflammatory diseases; and WTX-712, an activated Interleukin-21(IL-21) and WTX-518, an activated IL-18 (IL-18) INDUKINE molecule for the treatment of cancer. In addition, it develops WTX-1011, a conditionally activated INDUCER T cell engager molecule that targets STEAP 1 for prostate cancer, as well as WTX-2022 that targets CDH6 for ovarian and kidney cancer. Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Watertown, Massachusetts.
More stocks
- Kerjaya Prospek Property Bhd (7077.KL)
- OSE Pharma SA (OSE.PA)
- VirTra, Inc (VTSI)
- NUUO Inc. (6419.TWO)
- Aeon Motor Co Ltd (1599.TWO)
- REGO PAYMENT ARCHITECTURES, INC. (RPMT)
- Rein Therapeutics, Inc. (RNTX)
- LumenRadio AB (LUMEN.ST)
- Atlas Lithium Corp (ATLX)
- De Poan Pneumatic (1570.TWO)
- Charlotte's Web Holdings, Inc. (CWBHF)
- EgnsINVEST Ejendomme Tyskland A/S (EGNETY.CO)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.